ITGA2B and COVID-19: Mechanical thrombectomy (44 vs. 33.5%, p = 0.046) and GP IIb/IIIa inhibitor administration (20.9 vs. 11.2%, p = 0.007) were more frequent in COVID-19 patients [10].